Beyond Radiochemistry: An Integrated Translational Blueprint for the Next Generation of Radionuclide Ligand Conjugates
Journal of Nuclear Medicine · 2026-11 · 67 (11) · 1719-1724
DOI: 10.2967/jnumed.125.271853 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 06.08.2026. Verfasst von Chen Fu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Radioisotopes, Translational Research, Biomedical, Radiochemistry, Radiopharmaceuticals. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
- Pharmaceutical Sciences Laboratory Center, School of Pharmacy, China Medical University, Shenyang, China; and.
- Department of Pathology, Liaoning Cancer Hospital and Institute, Cancer Hospital of Dalian University of Technology, Shenyang, China lixiaoyan@cancerhosp-ln-cmu.com.
Zitieren
APA
Fu, C., & Li, X. (2026). Beyond Radiochemistry: An Integrated Translational Blueprint for the Next Generation of Radionuclide Ligand Conjugates. Journal of Nuclear Medicine, 67(11), 1719-1724. https://doi.org/10.2967/jnumed.125.271853
Vancouver
Fu C, Li X. Beyond Radiochemistry: An Integrated Translational Blueprint for the Next Generation of Radionuclide Ligand Conjugates. Journal of Nuclear Medicine. 2026;67(11):1719-1724. doi:10.2967/jnumed.125.271853
BibTeX
@article{Fu2026,
author = {Fu, Chen and Li, Xiaoyan},
title = {Beyond Radiochemistry: An Integrated Translational Blueprint for the Next Generation of Radionuclide Ligand Conjugates},
journal = {Journal of Nuclear Medicine},
year = {2026},
volume = {67},
number = {11},
pages = {1719--1724},
doi = {10.2967/jnumed.125.271853}
}
EUVIMED